Healthcare and pharmaceutical development
Customer: Zora Biosciences Oy, a VTT spin-off company
Market need: Improved prediction and diagnosis of human health and the development of personalized medicine applications for the pharmaceutical industry.
Application: Zora Biosciences Oy offers advanced laboratory services to meet the needs of pharmaceutical industry in the area of metabolomics and bioinformatics. The company also develops diagnostic applications for healthcare providers, for example, for the prediction of diabetes or cardiovascular disease risk.
Launching the business: The VTT spin-off Zora Biosciences Oy - www.zorabio.com - is one of very few companies in the world spelialized in metabolomics. The metabolomics service market is believed to grow to 1 billion USD by 2011. The in vitro diagnostics market was valued at 29 billion USD in 2005.